Two Class-1 Innovative Drugs Approved in China This Week: Fazanleseng Tablets and Nicalimumab Injection
May 22, 2026 16:39
CST Updated
17:00
Janssen
Biopharmaceutical R&D Developer
CSPC
Innovative Drug Research and Development, Manufacturer
Qilu Pharmaceutical
Specialty Formulations and Active Pharmaceutical Ingredients (API) Developer